| CMX | cefmenoxime |
|---|---|
| HCL | hairy-cell leukemia; human cultured lymphoblasts |
| HCl | hydrogen chloride |
| CMX | Cefmenoxime |
|---|---|
| Apo | Apomorphine HCl |
| HCL | Hairy Cell Leukaemia |
| DPPE | N,N-Diethyl-2-[4-(phenylmethyl) phenoxy]ethanamine.HCl |
| Gu.HCl | guanidinium chloride |
| cefmenoxime | <chemical> A cephalosporin antibiotic that is administered intravenously or intramuscularly. It is active against most common gram-positive and gram-negative microorganisms, is a potent inhibitor of enterobacteriaceae, and is highly resistant to hydrolysis by beta-lactamases. The drug has a high rate of efficacy in many types of infection and to date no severe side effects have been noted. Pharmacological action: cephalosporins. Chemical name: 5-Thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 7-(((2-amino-4-thiazolyl)(methoxyimino)acetyl)amino)-3-(((1-methyl-1H-tetrazol-5-yl)thio)methyl)-8-oxo-, (6R-(6alpha,7beta(Z)))- (12 Dec 1998) |
|---|
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|---|---|---|---|
|
º£½ºÆ®·ÐÁ¡¾ÈÁ¦ - »õâ
|
Senju |
E02690311 | Cefmenoxime HCl | Àü¹®ÀǾàǰ | ±Þ¿© |
|
¸Þ³ì¾ÂÁ¤ÁÖ1g - »õâ
|
»ï¼ºÁ¦¾à |
A02504801 | Cefmenoxime HCl | Àü¹®ÀǾàǰ | ±Þ¿© |
|
¸Þ³ì¾ÂÁ¤ÁÖ500mg - »õâ
|
»ï¼ºÁ¦¾à |
A02504791 | Cefmenoxime HCl | Àü¹®ÀǾàǰ | ±Þ¿© |
|
¼¼ÇÁ¸ß½ÉÁ¤ÁÖ1g - »õâ
|
»ïõ¸®Á¦¾à |
A02604241 | Cefmenoxime HCl | Àü¹®ÀǾàǰ | »èÁ¦ |
|
Ÿ¼¼ÇÁÁ¤ÁÖ500mg - »õâ
|
ÇÑÀϾàǰ°ø¾÷ |
A01002161 | Cefmenoxime HCl | Àü¹®ÀǾàǰ | »èÁ¦ |
|
Ÿ¼¼ÇÁÁ¤ÁÖ1g - »õâ
|
ÇÑÀϾàǰ°ø¾÷ |
A01002171 | Cefmenoxime HCl | Àü¹®ÀǾàǰ | »èÁ¦ |
|
µ¿¼º¼¼ÇÁ¸Þ³ì½ÉÁÖ1g - »õâ
|
µ¿¼ºÁ¦¾à |
A06750861 | Cefmenoxime HCl | Àü¹®ÀǾàǰ | »èÁ¦ |
|
¸Þ³ì¾Â±ÙÁÖ0.5g - »õâ
|
»ï¼ºÁ¦¾à |
A02504781 | Cefmenoxime HCl | Àü¹®ÀǾàǰ | »èÁ¦ |
|
¸Þ³ì¾ÂÁ¤ÁÖ2g - »õâ
|
»ï¼ºÁ¦¾à |
Cefmenoxime HCl | Àü¹®ÀǾàǰ | ¹Ì»ý»ê |
|
|
È޿½º¿°»ê¼¼ÇÁ¸Þ³ì½ÉÁÖ»ç1g - »õâ
|
È޿½º |
A29552301 | Cefmenoxime HCl | Àü¹®ÀǾàǰ | ±Þ¿© | ºÐ¾÷¿¹¿ÜÀǾàǰ |
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|